Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-060156
Filing Date
2018-11-28
Accepted
2018-11-28 18:59:33
Documents
2
Period of Report
2018-11-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2177
2 POA DOCUMENT poa.txt EX-24.3_818715 3945
  Complete submission text file 0001209191-18-060156.txt   7440
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address
Jackson Scott Thomas (Reporting) CIK: 0001566617 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36177 | Film No.: 181206706